These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Plasma monoaminergic metabolites and catecholamines in subarachnoid hemorrhage. Clinical implications. Minegishi A; Ishizaki T; Yoshida Y; Ahagon A; Shibata N; Kobayashi H Arch Neurol; 1987 Apr; 44(4):423-8. PubMed ID: 2435272 [TBL] [Abstract][Full Text] [Related]
11. Effects of handling or immobilization on plasma levels of 3,4-dihydroxyphenylalanine, catecholamines, and metabolites in rats. Kvetnanský R; Goldstein DS; Weise VK; Holmes C; Szemeredi K; Bagdy G; Kopin IJ J Neurochem; 1992 Jun; 58(6):2296-302. PubMed ID: 1573408 [TBL] [Abstract][Full Text] [Related]
12. Dexamethasone increases plasma HVA but not MHPG in normal humans. Wolkowitz OM; Sutton ME; Doran AR; Labarca R; Roy A; Thomas JW; Pickar D; Paul SM Psychiatry Res; 1985 Oct; 16(2):101-9. PubMed ID: 3865250 [TBL] [Abstract][Full Text] [Related]
13. Normal-range plasma catecholamines in patients with generalized and acrofacial vitiligo: preliminary report. Orecchia G; Frattini P; Cucchi ML; Santagostino G Dermatology; 1994; 189(4):350-3. PubMed ID: 7873818 [TBL] [Abstract][Full Text] [Related]
14. Plasma levels of brain derived-neurotrophic factor and catecholamine metabolites are increased during active phase of psychotic symptoms in CNS lupus: a case report. Ikenouchi A; Yoshimura R; Ikemura N; Utsunomiya K; Mitoma M; Nakamura J Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1359-63. PubMed ID: 16626841 [TBL] [Abstract][Full Text] [Related]
15. Effect of risperidone on plasma catecholamine metabolites and brain-derived neurotrophic factor in patients with bipolar disorders. Yoshimura R; Nakano Y; Hori H; Ikenouchi A; Ueda N; Nakamura J Hum Psychopharmacol; 2006 Oct; 21(7):433-8. PubMed ID: 17029305 [TBL] [Abstract][Full Text] [Related]
16. Central nervous system catecholamine metabolism in Korsakoff's psychosis. Martin PR; Weingartner H; Gordon EK; Burns RS; Linnoila M; Kopin IJ; Ebert MH Ann Neurol; 1984 Feb; 15(2):184-7. PubMed ID: 6200058 [TBL] [Abstract][Full Text] [Related]
17. Assessment of brain dopamine metabolism from plasma HVA and MHPG during debrisoquin treatment: validation in monkeys treated with MPTP. Kopin IJ; Bankiewicz KS; Harvey-White J Neuropsychopharmacology; 1988 May; 1(2):119-25. PubMed ID: 3266957 [TBL] [Abstract][Full Text] [Related]
18. Relationship between 3-methoxy-4-hydroxyphenylglycol and homovanillic acid in saliva and plasma of healthy volunteers. Yang RK; Yehuda R; Holland DD; Knott PJ Biol Psychiatry; 1997 Nov; 42(9):821-6. PubMed ID: 9347131 [TBL] [Abstract][Full Text] [Related]
19. Relationship between plasma and cerebrospinal fluid norepinephrine and dopamine metabolites in a nonhuman primate. Greene KA; Faull KF J Neurochem; 1989 Oct; 53(4):1007-13. PubMed ID: 2769251 [TBL] [Abstract][Full Text] [Related]
20. Plasma catecholamines and their metabolites in obsessive-compulsive disorder. Benkelfat C; Mefford IN; Masters CF; Nordahl TE; King AC; Cohen RM; Murphy DL Psychiatry Res; 1991 Jun; 37(3):321-31. PubMed ID: 1891512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]